Endothelin-1 mediated high glucose-induced epithelial-mesenchymal transition in renal tubular cells

Diabetes Research and Clinical Practice

Volumn 104, Issue 1, 2014, Pages 176-182

  Tang, Lin ^a   Li, Hui ^a   Gou, Rong ^a   Cheng, Genyang ^a   Guo, Yuanyuan ^a   Fang, Yudong ^a   Chen, Fengmei ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Diabetic nephropathy; Fibrosis; Hypoxia inducible factor

Indexed keywords

COBALT CHLORIDE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; UVOMORULIN; VIMENTIN; RNA;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REGULATION; ENZYME SYNTHESIS; EPITHELIAL MESENCHYMAL TRANSITION; INCUBATION TIME; KIDNEY TUBULE CELL; MOLECULAR MECHANICS; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOBLOTTING; KIDNEY TUBULE; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ENDOTHELIN-1; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GLUCOSE; IMMUNOBLOTTING; KIDNEY TUBULES; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SIGNAL TRANSDUCTION;

EID: 84898547220     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.12.021     Document Type: Article

References (37)

1. Mucsi I., Rosivall L. Epithelial-mesenchymal transition in renal tubular cells in the pathogenesis of progressive tubulo-interstitial fibrosis. Acta Physiol Hung 2007, 94:117-131.
2. Li Y., Yang J., Dai C., Wu C., Liu Y. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 2003, 112:503-516.
3. Oldfield M.D., Bach L.A., Forbes J.M., Nikolic-Paterson D., McRobert A., Thallas V., et al. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 2001, 108:1853-1863.
4. Jain R., Shaul P.W., Borok Z., Willis B.C. Endothelin-1 induces alveolar epithelial-mesenchymal transition through endothelin type A receptor-mediated production of TGF-beta1. Am J Respir Cell Mol Biol 2007, 37:38-47.
5. Rosano L., Spinella F., Di Castro V., Decandia S., Nicotra M.R., Natali P.G., et al. Endothelin-1 is required during epithelial to mesenchymal transition in ovarian cancer progression. Exp Biol Med (Maywood) 2006, 231:1128-1131.
6. Wang L., Yu Z., Mao T. Relationship between elevated plasma endothelin-1 level and renal function in patients with diabetic nephropathy. Zhonghua Nei Ke Za Zhi 1995, 34:318-321.
7. De Mattia G., Cassone-Faldetta M., Bellini C., Bravi M.C., Laurenti O., Baldoncini R., et al. Role of plasma and urinary endothelin-1 in early diabetic and hypertensive nephropathy. Am J Hypertens 1998, 11:983-988.
8. Tang L., Yi R., Yang B., Li H., Chen H., Liu Z. Valsartan inhibited HIF-1alpha pathway and attenuated renal interstitial fibrosis in streptozotocin-diabetic rats. Diabetes Res Clin Pract 2012, 97:125-131.
9. Simonson M.S., Ismail-Beigi F. Endothelin-1 increases collagen accumulation in renal mesangial cells by stimulating a chemokine and cytokine autocrine signaling loop. J Biol Chem 2011, 286:11003-11008.
10. Hoffman A., Abassi Z.A., Brodsky S., Ramadan R., Winaver J. Mechanisms of big endothelin-1-induced diuresis and natriuresis: role of ET(B) receptors. Hypertension 2000, 35:732-739.
11. Nambi P. Endothelin receptors in normal and diseased kidneys. Clin Exp Pharmacol Physiol 1996, 23:326-330.
12. Schildroth J., Rettig-Zimmermann J., Kalk P., Steege A., Fahling M., Sendeski M., et al. Endothelin type A and B receptors in the control of afferent and efferent arterioles in mice. Nephrol Dial Transplant 2011, 26:779-789.
13. Sasser J.M., Sullivan J.C., Hobbs J.L., Yamamato T., Pollock D.M., Carmines P.K., et al. Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism. J Am Soc Nephrol 2007, 18:143-154.
14. Longaretti L., Benigni A. Endothelin receptor selectivity in chronic renal failure. Eur J Clin Invest 2009, 39(Suppl. 2):32-37.
15. Meyers K.E., Sethna C. Endothelin antagonists in hypertension and kidney disease. Pediatr Nephrol 2013, 28:711-720.
16. Zeisberg M., Duffield J.S. Resolved EMT produces fibroblasts in the kidney. J Am Soc Nephrol 2010, 21:1247-1253.
17. Zeisberg M., Neilson E.G. Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 2010, 21:1819-1834.
18. Fragiadaki M., Mason R.M. Epithelial-mesenchymal transition in renal fibrosis - evidence for and against. Int J Exp Pathol 2011, 92:143-150.
19. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J Clin Invest 2009, 119:1420-1428.
20. Kriz W., Kaissling B., Le Hir M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy. J Clin Invest 2011, 121:468-474.
21. Rastaldi M.P., Ferrario F., Giardino L., Dell'Antonio G., Grillo C., Grillo P., et al. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int 2002, 62:137-146.
22. Vongwiwatana A., Tasanarong A., Rayner D.C., Melk A., Halloran P.F. Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis. Am J Transplant 2005, 5:1367-1374.
23. Saleh M.A., Pollock J.S., Pollock D.M. Distinct actions of endothelin A-selective versus combined endothelin A/B receptor antagonists in early diabetic kidney disease. J Pharmacol Exp Ther 2011, 338:263-270.
24. Dhaun N., Macintyre I.M., Melville V., Lilitkarntakul P., Johnston N.R., Goddard J., et al. Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease. Hypertension 2009, 54:113-119.
25. Han W.Q., Zhu Q., Hu J., Li P.L., Zhang F., Li N. Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells. Biochim Biophys Acta 2013, 6:1454-1462.
26. Schofield C.J., Ratcliffe P.J. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004, 5:343-354.
27. Wenger R.H., Stiehl D.P., Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci STKE 2005, 2005:re12.
28. Luo Y., He D.L., Ning L., Shen S.L., Li L., Li X. Hypoxia-inducible factor-1alpha induces the epithelial-mesenchymal transition of human prostate cancer cells. Chin Med J (Engl) 2006, 119:713-718.
29. Higgins D.F., Kimura K., Bernhardt W.M., Shrimanker N., Akai Y., Hohenstein B., et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 2007, 117:3810-3820.
30. Higgins D.F., Kimura K., Iwano M., Haase V.H. Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle 2008, 7:1128-1132.
31. Han W.Q., Zhu Q., Hu J., Li P.L., Zhang F., Li N. Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells. Biochim Biophys Acta 2013, 1833:1454-1462.
32. Wang Z., Tang L., Zhu Q., Yi F., Zhang F., Li P.L., et al. Hypoxia-inducible factor-1alpha contributes to the profibrotic action of angiotensin II in renal medullary interstitial cells. Kidney Int 2011, 79:300-310.
33. Zhu Q., Wang Z., Xia M., Li P.L., Van Tassell B.W., Abbate A., et al. Silencing of hypoxia-inducible factor-1alpha gene attenuated angiotensin II-induced renal injury in Sprague-Dawley rats. Hypertension 2011, 58:657-664.
34. Kanwar Y.S., Sun L., Xie P., Liu F.Y., Chen S. A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol Mech Dis 2011, 6:395-423.
35. Xu X., Chen P., Zheng Q., Wang Y., Chen W. Effect of pioglitazone on diabetic nephropathy and expression of HIF-1alpha and VEGF in the renal tissues of type 2 diabetic rats. Diabetes Res Clin Pract 2011, 93:63-69.
36. Cane G., Ginouvès A., Marchetti S., Busca R., Pouyssegur J., Berra E., et al. HIF-1α mediates the induction of IL-8 and VEGF expression on infection with Afa/Dr diffusely adhering E. coli and promotes EMT-like behaviour. Cell Microbiol 2010, 12(5):640-653.
37. Zhao J.H., Luo Y., Jiang Y.G., He D.L., Wu C.T. Knockdown of β-catenin through shRNA cause a reversal of EMT and metastatic phenotypes induced by HIF-1α. Cancer Invest 2011, 29(6):377-382.